Explore All Access
Check if your research matches the topics covered in YAKHAK HOEJI?
- Degree of match
- Common matching concepts
- Additional journal recommendations
YAKHAK HOEJI : Impact Factor & More
eISSN: 2383-9457pISSN: 0377-9556
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Topics Covered on YAKHAK HOEJI
Lipopolysaccharide
Amino acid
Systematic review
Gene expression
Community pharmacies
Inhibitory effect
Chronic disease
Hydrophobic polymer
YAKHAK HOEJI Journal Specifications
| Overview | |
| Publisher | PHARMACEUTICAL SOC KOREA |
| Frequency | Quarterly |
| General Details |
View less
Planning to publish in YAKHAK HOEJI ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in YAKHAK HOEJI
선택적 세로토닌 재흡수 억제제에 의한 망막색소상피세포의 자가포식 유도
- 31 Oct 2024
- Yakhak Hoeji
Analysis of Weight Loss and Lipid-lowering Adverse Events in Chronic Hepatitis B Patients treated with Tenofovir Disoproxil Fumarate : Using Korea adverse event reporting system database and U.S. Food and Drug Administration adverse event reporting system database
- 31 Oct 2024
- Yakhak Hoeji
외국의 약제 사용범위 확대 정책의 현황: 호주, 영국 및 일본
- 31 Oct 2024
- Yakhak Hoeji
메조포러스실리카를 이용한 페북소스타트 고체분산체 개발
- 31 Oct 2024
- Yakhak Hoeji
자극 반응성 하이드로겔을 이용한 감염성 피부 창상 치료제 개발의 최신 연구 동향
- 31 Oct 2024
- Yakhak Hoeji
의약품 점자 표시 국내외 가이드라인의 비교분석 연구
- 31 Oct 2024
- Yakhak Hoeji
선택적 세로토닌 재흡수 억제제에 의한 망막색소상피세포의 자가포식 유도
- 31 Oct 2024
- Yakhak Hoeji
Analysis of Weight Loss and Lipid-lowering Adverse Events in Chronic Hepatitis B Patients treated with Tenofovir Disoproxil Fumarate : Using Korea adverse event reporting system database and U.S. Food and Drug Administration adverse event reporting system database
- 31 Oct 2024
- Yakhak Hoeji
외국의 약제 사용범위 확대 정책의 현황: 호주, 영국 및 일본
- 31 Oct 2024
- Yakhak Hoeji
메조포러스실리카를 이용한 페북소스타트 고체분산체 개발
- 31 Oct 2024
- Yakhak Hoeji
자극 반응성 하이드로겔을 이용한 감염성 피부 창상 치료제 개발의 최신 연구 동향
- 31 Oct 2024
- Yakhak Hoeji
의약품 점자 표시 국내외 가이드라인의 비교분석 연구
- 31 Oct 2024
- Yakhak Hoeji
Compare Similar Journals with YAKHAK HOEJI
Select Journals to Compare with YAKHAK HOEJI
Total journals - 9
You can select up to 3 Journals at a time
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
International Journal of Environmental Research and Public Health
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
Molecules
Publisher: MDPI
Scientific Reports
Publisher: NATURE PORTFOLIO
International Journal of Molecular Sciences
Publisher: MDPI
Science of the Total Environment
Publisher: ELSEVIER
Open Forum Infectious Diseases
Publisher: OXFORD UNIV PRESS INC
Environmental Science and Pollution Research
Publisher: SPRINGER HEIDELBERG
0 Journals Selected to compare with
YAKHAK HOEJI
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on YAKHAK HOEJI
What is the publishing frequency of YAKHAK HOEJI? 
YAKHAK HOEJI published with a Quarterly frequency.
How many articles did YAKHAK HOEJI publish last year?
In 2023, YAKHAK HOEJI publsihed 53 articles.
What is the eISSN & pISSN for YAKHAK HOEJI?
For YAKHAK HOEJI, eISSN is 2383-9457 and pISSN is 0377-9556.
Who is the publisher of YAKHAK HOEJI?
PHARMACEUTICAL SOC KOREA is the publisher of YAKHAK HOEJI.
